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Angiostrongylus cantonensis, the rat lungworm, is the most 
common infectious cause of eosinophilic meningoencephali-
tis worldwide. This parasite is endemic to Southeast Asia and 
the Pacific Islands, and its global distribution is increasing. 
We report A. cantonensis meningoencephalitis in a 12-month-
old boy in Tennessee, USA, who had not traveled outside of 
southwestern Tennessee or northwestern Mississippi.
In 2016, a 12-month-old, fully vaccinated boy was admit-ted to a hospital in Memphis, Tennessee, USA, for evalu-
ation of 18 days of daily fever, irritability, decreased oral 
intake, and emesis. His medical history was unremarkable, 
and he had no known contact with sick persons. He had not 
traveled outside the area comprising southwestern Tennes-
see and northwestern Mississippi. He lived in a nonagricul-
tural rural area and was exposed to a vaccinated family dog. 
Wild rats had been observed in and around the home, and 
rat droppings had been found in the child’s bed. Raccoons 
were seen on the property; however, contact, either direct or 
through fomites such as latrines, was not reported. During a 
17-day period, 2 evaluations by his primary care physician 
and 4 emergency department visits resulted in the diagnosis 
of fever of unknown origin and inpatient admission.
A cerebrospinal fluid (CSF) sample taken by lumbar 
puncture on day 20 of illness showed eosinophil-predom-
inant pleocytosis, mild hypoglycorrhacia, and a mildly el-
evated protein level (Table). Magnetic resonance imaging 
of the brain and spine showed scattered areas of restricted 
diffusion throughout the brain parenchyma, leptomeningeal 
enhancement, and multifocal nodular enhancement along 
the ventral portion of multiple spinal levels. Serologic test-
ing was negative for Toxocara canis/cati, Strongyloides 
stercoralis, Ehrlichia chaffeenis, Rickettsia rickettsiae, 
Epstein-Barr virus, HIV, and Toxoplasma gondii; a rapid 
plasma reagin was also negative. Tuberculin skin testing 
was negative. Results of CSF PCR for Streptococcus pneu-
moniae, herpes simplex virus, and enteroviruses were neg-
ative; CSF cryptococcal antigen testing was also negative. 
Due to concern for infection with Baylisascaris procyonis, 
the raccoon roundworm, physicians prescribed albendazole 
and dexamethasone. The patient’s temperature returned to 
normal, and his symptoms resolved. Upon discharge, he 
was to complete 3 weeks of albendazole and tapering doses 
of corticosteroids. Attending physicians repeated lumbar 
punctures on days 28, 41, and 56 (Table). 
Physicians sent samples (CSF and serum) taken on 
day 20  to the Centers for Disease Control and Prevention 
(Atlanta, GA, USA) to test for B. procyonis roundworms 
and samples taken on day 56 to test for Angiostrongylus 
cantonensis, the rat lungworm. Results were negative for 
B. procyonis but positive for A. cantonensis. In addition, 
serum samples obtained at the time of the initial lumbar 
puncture were positive for A. cantonensis antibodies by in-
vestigational whole-worm Western blot.
The first documented human infection with A. can-
tonensis worms occurred in 1944 in Taiwan. Since then, 
>2,800 cases among humans have been reported; most 
have been in Southeast Asia and the Pacific islands (1; 
online Technical Appendix, https://wwwn.cdc.gov/EID/
article/23/10/17-0978-Techapp1.pdf). In the late 1950s, 
the first report of human A. cantonensis infection in the 
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United States occurred in Hawaii. A. cantonensis worms 
have since become endemic to wide-ranging tropical and 
subtropical locales in the Western Hemisphere, including 
the Hawaiian Islands (2), the Caribbean Islands (3), and 
South America (4).
The first report of the rat lungworm in the continental 
United States was in 1987, when Kim et al. found that 18% 
of rats sampled on necropsy in New Orleans, Louisiana, 
were infected with the nematode (5). First-stage A. can-
tonensis larvae from these rats produced infections in na-
tive gastropods, providing the potential for these parasites 
to become endemic to the region. A report ≈15 years later 
documented infection in vertebrates not only in New Or-
leans but also in other areas of Louisiana and Mississippi. 
A. cantonensis worms are now considered to be endemic 
to Louisiana (5). Infection has since been documented in 
rats (6), gastropods (7), and vertebrates (8) across a large 
area of the southern United States, from Oklahoma (6) to 
Florida (7,8).
Soon after the initial recognition in local animal res-
ervoirs, the first reported A. cantonensis infection in a hu-
man acquired in the continental United States occurred in 
an 11-year-old boy residing in New Orleans. Since then, 3 
additional cases have been reported in an 11-month-old, a 
12-month-old, and a 19-month-old, all of whom resided in 
Houston, Texas, and had not traveled (9).
A. cantonensis infection causes a self-limited illness in 
which headaches, nonfocal neurologic findings, and cranial 
nerve involvement are the most common signs and symp-
toms. Optimal therapy has not been clearly defined, and 
symptomatic management is an option for this self-limited 
illness. When therapy is prescribed, corticosteroids alone 
or in combination with antihelminth medications are most 
commonly used. In a prospective study that followed up 
on 3 previous studies, Chotmongkol et al. confirmed that a 
2-week course of corticosteroids shortened the duration of 
headache and reduced the need for repeated lumbar punc-
ture (10). The study concluded that corticosteroids plus al-
bendazole was no better than corticosteroids alone.
International shipping and the ability of A. cantonensis 
worms to use diverse species of gastropods as intermedi-
ate hosts have all contributed to this parasite becoming a 
pathogen of increasing public health concern (5). Angio-
strongyliasis should be considered in the differential diag-
nosis of prolonged fever of unknown origin with compat-
ible clinical and laboratory findings.
Dr. Flerlage is a second-year fellow in a combined fellowship 
program for training in pediatric infectious diseases and  
critical care medicine at University of Tennessee/St. 
Jude Children’s Research Hospital. His primary research 
interest is acute lung injury caused by respiratory viruses in 
immunocompromised patients.
References
  1. Wang Q-P, Wu Z-D, Wei J, Owen RL, Lun Z-R. Human  
Angiostrongylus cantonensis: an update. Eur J Clin Microbiol Infect 
Dis. 2012;31:389–95. http://dx.doi.org/10.1007/s10096-011-1328-5
  2. Rosen L, Chappell R, Laqueur GL, Wallace GD, Weinstein PP. 
Eosinophilic meningoencephalitis caused by a metastrongylid  
lung-worm of rats. JAMA. 1962;179:620–4. http://dx.doi.org/ 
10.1001/jama.1962.03050080032007
  3. Waugh CA, Lindo JF, Lorenzo-Morales J, Robinson RD. An 
epidemiological study of A. cantonensis in Jamaica subsequent 
to an outbreak of human cases of eosinophilic meningitis in 
2000. Parasitology. 2016;143:1211–7. http://dx.doi.org/10.1017/
S0031182016000640
  4. Simoes RO, Monteiro FA, Sanchez E, Thiengo SC, Garcia JS,  
Costa-Neto SF, et al. Endemic angiostrongyliasis, Rio de  
Janeiro, Brazil. Emerg Infect Dis. 2011;17:1331–3.  
http://dx.doi.org/10.3201/eid1707.101822
  5. Kim DY, Stewart TB, Bauer RW, Mitchell M. Parastrongylus 
(=Angiostrongylus) cantonensis now endemic in Louisiana wildlife. 
J Parasitol. 2002;88:1024–6. http://dx.doi.org/10.1645/0022-3395 
(2002)088[1024:PACNEI]2.0.CO;2
  6. York EM, Creecy JP, Lord WD, Caire W. Geographic range 
expansion for rat lungworm in North America. Emerg Infect Dis. 
2015;21:1234–6. http://dx.doi.org/10.3201/eid2107.141980
  7. Stockdale-Walden HD, Slapcinsky J, Qvarnstrom Y, McIntosh A, 
Bishop HS, Rosseland B. Angiostrongylus cantonensis in  
introduced gastropods in Southern Florida. J Parasitol. 
2015;101:156–9. http://dx.doi.org/10.1645/14-553.1
  8. Duffy MS, Miller CL, Kinsella JM, de Lahunta A. Parastrongylus 
cantonensis in a nonhuman primate, Florida. Emerg Infect Dis. 
2004;10:2207–10. http://dx.doi.org/10.3201/eid1012.040319
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 10, October 2017 1757
RESEARCH LETTERS
 
Table. Results of cerebrospinal fluid testing for 12-month-old boy with meningoencephalitis, Memphis, Tennessee, USA, 2016* 
Test Reference range 
Day of illness 
20 28 41 56 
Leukocytes, cells/mm3 0–8 547 55 2,979 115 
 Polymorphonuclear cells, % 0–1 0 4 20 4 
 Lymphocytes, % 0–5 44 80 65 64 
 Monocytes, % 0–5 20 6 10 21 
 Eosinophils, % NA 36 10 5 11 
Erythrocytes <0 0 14 0 45 
Glucose, mg/dL 40–70 37 25 22 27 
Protein, mg/dL 15–45 67 74 164 104 










Bacterial culture NA Sterile Sterile Sterile Sterile 
*NA, not applicable. 
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Since April 2017, a dengue fever outbreak has been ongo-
ing in Côte d’Ivoire. We diagnosed dengue fever (type 2 
virus) in a traveler returning to Japan from Côte d’Ivoire. 
Phylogenetic analysis revealed strain homology with the 
Burkina Faso 2016 strain. This case may serve as an alert 
to possible disease spread outside Africa.
In recent decades, dengue virus (DENV) infection has been spreading worldwide. Although in Africa the lead-
ing cause of acute febrile illness is still malaria, dengue has 
recently gained momentum (1). Dengue has been reported 
in 34 African countries, although it has probably been un-
derreported because of the lack of diagnostic testing and 
systematic surveillance in Africa (2). Four types of virus 
have been isolated; the most endemic to Africa is DENV 
type 2 (DENV-2), followed by DENV-1 (2). The first re-
ported case of DENV-1 infection occurred in a young sol-
dier from Abidjan, Côte d’Ivoire, in 1999 (3). At that time, 
no other similar cases or epidemics in Abidjan had been 
reported. In 2008, a closely related strain, DENV-3, was 
isolated from visitors to Côte d’Ivoire (4,5). In 2010, den-
gue fever was biologically confirmed for 7 patients who 
had never been in a dengue-endemic area, and DENV-3 
was confirmed by reverse transcription PCR for 4 of these 
patients (6). A prospective study in Abidjan also revealed 
that DENV-3 had been the cause of febrile illness during 
2011–2012 (7). Thus, DENV-3 may have circulated widely 
in Côte d’Ivoire, especially in Abidjan. During the 2016 
outbreak in Burkina Faso, DENV-2 infection was detected 
in 2 travelers returning from Burkina Faso to France (8). 
During August–November 2016, the World Health Organi-
zation reported 1,061 probable dengue cases and 15 deaths 
from dengue (9). We report a case of dengue fever exported 
to Japan from Abidjan in 2017.
On June 19, 2017, a man in his early 50s sought care at 
the Center Hospital of the National Center for Global Health 
and Medicine, Tokyo, Japan, for fever, chills, headache, and 
mild joint pain. In June 2013, he had traveled to Abidjan for 
business, and on June 13, 2017, he returned to Japan. He 
had been vaccinated for yellow fever. He had noticed a high 
fever in the morning and sought care the same evening. 
Physical examination revealed body temperature of 
39.3°C, mildly hyperemic conjunctiva, and a slight rash on 
his trunk. His blood biochemistry profile showed 3,640 × 109 
leukocytes/L, hemoglobin level 13.5 g/dL, and 151 × 109 
thrombocytes/L. Results of a rapid diagnostic test for malar-
ia (BinaxNOW Malaria; Alere, Waltham, MA, USA) were 
negative. A thin-coated peripheral blood smear with May-
Grünwald Giemsa stain showed no Plasmodium parasites. 
Results of a dengue rapid diagnostic test (Dengue Duo NS1 
Ag + Ab Combo; Alere) were negative for IgM and IgG but 
positive for nonstructural protein 1 antigen. Serum samples 
obtained on June 19 and 26 were sent for real-time reverse 
transcription PCR to the National Institute of Infectious Dis-
eases, Tokyo, where DENV-2 RNA was detected. 
The patient’s signs and symptoms resolved spontane-
ously in a week; his lowest thrombocyte count was 99 × 109 
thrombocytes/L. On June 19, a diagnostic test for DENV 
IgM (Dengue Virus IgM Capture ELISA; Focus Diagnos-
tics, Cypress, CA, USA) yielded negative results; however, 
on June 26, positive results indicated seroconversion. 
Phylogenetic analysis of the DENV envelope gene indi-
cated that the sequence of DENV-2 obtained from the patient 
belonged to the cosmopolitan genotype and was 99% identi-
cal with the envelope gene of DENV-2 strains from the 2016 
dengue epidemic in Burkina Faso (GenBank accession nos. 
LC206003, KY627763, and KY627762) (Figure). The se-
quence of DENV-2 from the patient also showed 97% identity 
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